compare glp 1 agonists glp-1 drug comparison Market Overview: and the Obesity Market Meta-analysis comparing effects of short-and

PMID: 23287849

BPC-157 is not FDA-approved for any therapeutic use

Examples Sitagliptin (Januvia) Dosage Initial: 25100 mg once daily (depending on kidney function) Maximum: 100 mg once daily Saxagliptin (Onglyza) Dosage Initial: 2.55 mg once daily Maximum: 5 mg once daily Linagliptin (Tradjenta) Dosage Initial: 5 mg once daily Maximum: 5 mg once daily Alogliptin (Nesina) Dosage Initial: 6.2525 mg once daily (depending on kidney function) Maximum: 25 mg once daily Possible side effects include: Acute pancreatitis (this appears to be rare) Severe joint pain Thiazolidinediones (TZDs) Primary mechanism(s) of action Modulation of glucose and lipid metabolism via activation of the PPAR-gamma nuclear hormone receptor

It is also given by IV to improve immune function in people with HIV/AIDS, and to people who have had a heart attack

When this lining becomes damaged or inflamed, it reduces the ability of blood vessels to expand and contract